Crescent Biopharma Inc. (CBIO)
Market is closed
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
- 1 - 5
- Next >>
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Biotechnology Value Fund / BVF Inc Mark Lampert | 2,748,763 | $32,600,329 | +99% | 1.1% |
| 2. | Vestal Point Capital Ryan Wilder | 1,500,000 | $17,790,000 | 0.6% | |
| 3. | Opaleye Management James A. Silverman | 1,178,300 | $13,974,638 | 1.84% | |
| 4. | Tang Capital Management Kevin C. Tang | 872,398 | $10,346,640 | +29% | 0.51% |
| 5. | ADAR1 Capital Management Daniel Schneeberger | 606,000 | $7,187,160 | 0.53% |
Hedge Fund Resource Center